CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C05104 | BRD-K08525451 | sarafloxacin | -- | -- | -- | Details |
| C05105 | BRD-K08527280 | BRD-K08527280 | -- | -- | -- | Details |
| C05106 | BRD-K08533345 | BRD-K08533345 | -- | -- | -- | Details |
| C05107 | BRD-K08534346 | BRD-K08534346 | -- | -- | -- | Details |
| C05108 | BRD-K08540981 | BRD-K08540981 | -- | -- | -- | Details |
| C05109 | BRD-K08541433 | cdk/crk-inhibitor | -- | -- | -- | Details |
| C05110 | BRD-K08542803 | gambogic-acid | BCL2 | HSP inhibitor; Caspase activator; Topoisomerase inhibitor; MYC expression inhibitor; Telomerase reverse transcriptase expression inhibitor | -- | Details |
| C05111 | BRD-K08547377 | irinotecan | TOP1 | Topoisomerase inhibitor | -- | Details |
| C05112 | BRD-K08554278 | bisbenzimide | TOP1 | DNA binding agent | -- | Details |
| C05113 | BRD-K08556791 | ethoprop | ACHE | Acetylcholinesterase inhibitor | -- | Details |
| C05114 | BRD-K08558441 | BRD-K08558441 | -- | -- | -- | Details |
| C05115 | BRD-K08565465 | BRD-K08565465 | -- | -- | -- | Details |
| C05116 | BRD-K08570368 | BRD-K08570368 | -- | -- | -- | Details |
| C05117 | BRD-K08576275 | BRD-K08576275 | -- | -- | -- | Details |
| C05118 | BRD-K08585415 | BRD-K08585415 | -- | -- | -- | Details |
| C05119 | BRD-K08586861 | ramatroban | PTGDR2; TBXA2R | Prostanoid receptor antagonist | -- | Details |
| C05120 | BRD-K08589866 | linsitinib | IGF1R; INSR | IGF-1 inhibitor | -- | Details |
| C05121 | BRD-K08590382 | BRD-K08590382 | -- | -- | -- | Details |
| C05122 | BRD-K08593711 | BRD-K08593711 | -- | -- | -- | Details |
| C05123 | BRD-K08594759 | BRD-K08594759 | -- | -- | -- | Details |
| C05124 | BRD-K08607084 | BRD-K08607084 | -- | -- | -- | Details |
| C05125 | BRD-K08607520 | BRD-K08607520 | -- | -- | -- | Details |
| C05126 | BRD-K08614872 | BRD-K08614872 | -- | -- | -- | Details |
| C05127 | BRD-K08616215 | BRD-K08616215 | -- | -- | -- | Details |
| C05128 | BRD-K08617930 | BRD-K08617930 | -- | -- | -- | Details |
| C05129 | BRD-K08618283 | BRD-K08618283 | -- | -- | -- | Details |
| C05130 | BRD-K08619574 | thioproperazine | -- | -- | -- | Details |
| C05131 | BRD-K08619838 | tremorine | -- | -- | -- | Details |
| C05132 | BRD-K08624646 | BRD-K08624646 | -- | -- | -- | Details |
| C05133 | BRD-K08629159 | BRD-K08629159 | -- | -- | -- | Details |
| C05134 | BRD-K08630646 | BRD-K08630646 | -- | -- | -- | Details |
| C05135 | BRD-K08640512 | RS-100329 | ADRA1A | Adrenergic receptor antagonist | -- | Details |
| C05136 | BRD-K08640787 | BRD-K08640787 | -- | -- | -- | Details |
| C05137 | BRD-K08647020 | BRD-K08647020 | -- | -- | -- | Details |
| C05138 | BRD-K08650286 | BRD-K08650286 | -- | -- | -- | Details |
| C05139 | BRD-K08656311 | BRD-K08656311 | -- | -- | -- | Details |
| C05140 | BRD-K08658757 | BRD-K08658757 | -- | -- | -- | Details |
| C05141 | BRD-K08659289 | BRD-K08659289 | -- | -- | -- | Details |
| C05142 | BRD-K08663380 | BRD-K08663380 | -- | -- | -- | Details |
| C05143 | BRD-K08666983 | BRD-K08666983 | -- | -- | -- | Details |
| C05144 | BRD-K08668362 | BRD-K08668362 | -- | -- | -- | Details |
| C05145 | BRD-K08679933 | BRD-K08679933 | -- | -- | -- | Details |
| C05146 | BRD-K08681769 | ibandronic-acid | -- | -- | -- | Details |
| C05147 | BRD-K08697762 | aminoresveratrol | -- | -- | -- | Details |
| C05148 | BRD-K08702524 | BRD-K08702524 | -- | -- | -- | Details |
| C05149 | BRD-K08703257 | BRD-K08703257 | -- | -- | 3-amino-benzamide | Details |
| C05150 | BRD-K08703292 | BRD-K08703292 | -- | -- | -- | Details |
| C05151 | BRD-K08706435 | BRD-K08706435 | -- | -- | -- | Details |
| C05152 | BRD-K08707982 | BRD-K08707982 | -- | -- | -- | Details |
| C05153 | BRD-K08713111 | BRD-K08713111 | -- | -- | -- | Details |
| C05154 | BRD-K08714182 | sericetin | -- | -- | -- | Details |
| C05155 | BRD-K08715020 | BRD-K08715020 | -- | -- | -- | Details |
| C05156 | BRD-K08715132 | BRD-K08715132 | -- | -- | -- | Details |
| C05157 | BRD-K08715918 | BRD-K08715918 | -- | -- | -- | Details |
| C05158 | BRD-K08720480 | BRD-K08720480 | -- | -- | -- | Details |
| C05159 | BRD-K08722369 | BRD-K08722369 | -- | -- | -- | Details |
| C05160 | BRD-K08723967 | BRD-K08723967 | -- | -- | -- | Details |
| C05161 | BRD-K08725381 | BRD-K08725381 | -- | -- | -- | Details |
| C05162 | BRD-K08725721 | BRD-K08725721 | -- | -- | -- | Details |
| C05163 | BRD-K08727137 | alfadolone | -- | -- | -- | Details |
| C05164 | BRD-K08730634 | BRD-K08730634 | -- | -- | -- | Details |
| C05165 | BRD-K08730943 | BRD-K08730943 | -- | -- | -- | Details |
| C05166 | BRD-K08731287 | BRD-K08731287 | -- | -- | -- | Details |
| C05167 | BRD-K08750028 | BRD-K08750028 | -- | -- | -- | Details |
| C05168 | BRD-K08751619 | BRD-K08751619 | -- | -- | -- | Details |
| C05169 | BRD-K08753635 | BRD-K08753635 | -- | -- | -- | Details |
| C05170 | BRD-K08754235 | BRD-K08754235 | -- | -- | -- | Details |
| C05171 | BRD-K08759542 | BRD-K08759542 | -- | -- | -- | Details |
| C05172 | BRD-K08760804 | BRD-K08760804 | -- | -- | -- | Details |
| C05173 | BRD-K08777248 | BRD-K08777248 | -- | -- | -- | Details |
| C05174 | BRD-K08781018 | BRD-K08781018 | -- | -- | -- | Details |
| C05175 | BRD-K08799216 | pelitinib | EGFR | EGFR inhibitor | -- | Details |
| C05176 | BRD-K08799663 | BRD-K08799663 | -- | -- | -- | Details |
| C05177 | BRD-K08799867 | BRD-K08799867 | -- | -- | -- | Details |
| C05178 | BRD-K08799912 | BRD-K08799912 | -- | -- | -- | Details |
| C05179 | BRD-K08799950 | BRD-K08799950 | -- | -- | -- | Details |
| C05180 | BRD-K08805764 | BRD-K08805764 | -- | -- | -- | Details |
| C05181 | BRD-K08806317 | timolol | ADRB1; ADRB2 | Adrenergic receptor antagonist | -- | Details |
| C05182 | BRD-K08806664 | BRD-K08806664 | -- | -- | -- | Details |
| C05183 | BRD-K08807999 | NO-ASA | PTGS2 | Cyclooxygenase inhibitor | no-asa | Details |
| C05184 | BRD-K08811598 | BRD-K08811598 | -- | -- | -- | Details |
| C05185 | BRD-K08813275 | BRD-K08813275 | -- | -- | -- | Details |
| C05186 | BRD-K08817808 | BRD-K08817808 | -- | -- | -- | Details |
| C05187 | BRD-K08828851 | BRD-K08828851 | -- | -- | -- | Details |
| C05188 | BRD-K08829593 | BRD-K08829593 | -- | -- | -- | Details |
| C05189 | BRD-K08829932 | BRD-K08829932 | -- | -- | -- | Details |
| C05190 | BRD-K08831772 | BRD-K08831772 | -- | -- | -- | Details |
| C05191 | BRD-K08832567 | naringenin | CYP19A1; ESR2 | TRPV antagonist; Aromatase inhibitor | -- | Details |
| C05192 | BRD-K08835142 | BRD-K08835142 | -- | -- | -- | Details |
| C05193 | BRD-K08844227 | BRD-K08844227 | -- | -- | -- | Details |
| C05194 | BRD-K08845546 | tacrolimus | FKBP1A | Calcineurin inhibitor | -- | Details |
| C05195 | BRD-K08846320 | BRD-K08846320 | -- | -- | -- | Details |
| C05196 | BRD-K08852751 | BRD-K08852751 | -- | -- | -- | Details |
| C05197 | BRD-K08856548 | BG-1016 | -- | -- | -- | Details |
| C05198 | BRD-K08856690 | BRD-K08856690 | -- | -- | -- | Details |
| C05199 | BRD-K08857385 | BRD-K08857385 | -- | -- | -- | Details |
| C05200 | BRD-K08859203 | DU-728 | ITGA2B; ITGB3 | Structural glycoprotein antagonist | -- | Details |
| C05201 | BRD-K08862633 | TMP-269 | -- | -- | -- | Details |
| C05202 | BRD-K08867654 | BRD-K08867654 | -- | -- | -- | Details |
| C05203 | BRD-K08878345 | BRD-K08878345 | -- | -- | -- | Details |